vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.
Purple Innovation, Inc. is the larger business by last-quarter revenue ($140.7M vs $123.8M, roughly 1.1× NATURES SUNSHINE PRODUCTS INC). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -2.3%, a 5.6% gap on every dollar of revenue. On growth, Purple Innovation, Inc. posted the faster year-over-year revenue change (9.1% vs 4.7%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $-7.8M). Over the past eight quarters, Purple Innovation, Inc.'s revenue compounded faster (8.3% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
NATR vs PRPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $140.7M |
| Net Profit | $4.1M | $-3.2M |
| Gross Margin | 72.5% | 41.9% |
| Operating Margin | 4.3% | -1.6% |
| Net Margin | 3.3% | -2.3% |
| Revenue YoY | 4.7% | 9.1% |
| Net Profit YoY | 1379.4% | 62.1% |
| EPS (diluted) | $0.23 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $140.7M | ||
| Q3 25 | $128.3M | $118.8M | ||
| Q2 25 | $114.8M | $105.1M | ||
| Q1 25 | $113.2M | $104.2M | ||
| Q4 24 | $118.2M | $129.0M | ||
| Q3 24 | $114.6M | $118.6M | ||
| Q2 24 | $110.6M | $120.3M | ||
| Q1 24 | $111.0M | $120.0M |
| Q4 25 | $4.1M | $-3.2M | ||
| Q3 25 | $5.3M | $-11.7M | ||
| Q2 25 | $5.3M | $-17.3M | ||
| Q1 25 | $4.7M | $-19.1M | ||
| Q4 24 | $-321.0K | $-8.5M | ||
| Q3 24 | $4.3M | $-39.2M | ||
| Q2 24 | $1.3M | $27.0K | ||
| Q1 24 | $2.3M | $-50.2M |
| Q4 25 | 72.5% | 41.9% | ||
| Q3 25 | 73.3% | 42.8% | ||
| Q2 25 | 71.7% | 35.9% | ||
| Q1 25 | 72.1% | 39.4% | ||
| Q4 24 | 72.0% | 42.9% | ||
| Q3 24 | 71.3% | 29.7% | ||
| Q2 24 | 71.4% | 40.7% | ||
| Q1 24 | 71.2% | 34.8% |
| Q4 25 | 4.3% | -1.6% | ||
| Q3 25 | 7.0% | -10.2% | ||
| Q2 25 | 3.7% | -13.5% | ||
| Q1 25 | 5.4% | -13.9% | ||
| Q4 24 | 3.8% | -6.0% | ||
| Q3 24 | 4.6% | -39.5% | ||
| Q2 24 | 5.1% | -12.1% | ||
| Q1 24 | 4.2% | -19.3% |
| Q4 25 | 3.3% | -2.3% | ||
| Q3 25 | 4.2% | -9.9% | ||
| Q2 25 | 4.6% | -16.5% | ||
| Q1 25 | 4.2% | -18.4% | ||
| Q4 24 | -0.3% | -6.6% | ||
| Q3 24 | 3.8% | -33.1% | ||
| Q2 24 | 1.2% | 0.0% | ||
| Q1 24 | 2.1% | -41.8% |
| Q4 25 | $0.23 | $0.03 | ||
| Q3 25 | $0.30 | $0.11 | ||
| Q2 25 | $0.28 | $0.16 | ||
| Q1 25 | $0.25 | $0.18 | ||
| Q4 24 | $-0.02 | $0.08 | ||
| Q3 24 | $0.23 | $0.36 | ||
| Q2 24 | $0.07 | $0.00 | ||
| Q1 24 | $0.12 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $24.3M |
| Total DebtLower is stronger | — | $126.7M |
| Stockholders' EquityBook value | $161.6M | $-29.7M |
| Total Assets | $261.1M | $296.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $24.3M | ||
| Q3 25 | $95.6M | $32.4M | ||
| Q2 25 | $81.3M | $34.2M | ||
| Q1 25 | $86.5M | $21.6M | ||
| Q4 24 | $84.7M | $29.0M | ||
| Q3 24 | $78.7M | $23.4M | ||
| Q2 24 | $68.7M | $23.4M | ||
| Q1 24 | $77.8M | $34.5M |
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $-29.7M | ||
| Q3 25 | $166.7M | $-26.9M | ||
| Q2 25 | $163.7M | $-15.6M | ||
| Q1 25 | $167.1M | $1.3M | ||
| Q4 24 | $161.0M | $20.2M | ||
| Q3 24 | $162.6M | $28.0M | ||
| Q2 24 | $156.4M | $66.4M | ||
| Q1 24 | $159.7M | $65.5M |
| Q4 25 | $261.1M | $296.3M | ||
| Q3 25 | $264.8M | $302.1M | ||
| Q2 25 | $254.9M | $303.8M | ||
| Q1 25 | $252.7M | $293.8M | ||
| Q4 24 | $240.9M | $307.8M | ||
| Q3 24 | $245.3M | $309.3M | ||
| Q2 24 | $235.8M | $362.1M | ||
| Q1 24 | $247.3M | $382.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $-5.8M |
| Free Cash FlowOCF − Capex | $7.6M | $-7.8M |
| FCF MarginFCF / Revenue | 6.1% | -5.5% |
| Capex IntensityCapex / Revenue | 1.9% | 1.4% |
| Cash ConversionOCF / Net Profit | 2.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $-41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $-5.8M | ||
| Q3 25 | $18.5M | $-968.0K | ||
| Q2 25 | $4.3M | $-4.0M | ||
| Q1 25 | $2.6M | $-23.1M | ||
| Q4 24 | $12.2M | $6.8M | ||
| Q3 24 | $9.6M | $1.1M | ||
| Q2 24 | $1.3M | $-8.9M | ||
| Q1 24 | $2.2M | $-16.8M |
| Q4 25 | $7.6M | $-7.8M | ||
| Q3 25 | $16.8M | $-1.8M | ||
| Q2 25 | $3.0M | $-7.0M | ||
| Q1 25 | $1.5M | $-25.3M | ||
| Q4 24 | $10.0M | $5.7M | ||
| Q3 24 | $7.9M | $101.0K | ||
| Q2 24 | $-2.0M | $-11.0M | ||
| Q1 24 | $-1.5M | $-19.9M |
| Q4 25 | 6.1% | -5.5% | ||
| Q3 25 | 13.1% | -1.5% | ||
| Q2 25 | 2.6% | -6.6% | ||
| Q1 25 | 1.3% | -24.3% | ||
| Q4 24 | 8.5% | 4.4% | ||
| Q3 24 | 6.9% | 0.1% | ||
| Q2 24 | -1.9% | -9.2% | ||
| Q1 24 | -1.4% | -16.5% |
| Q4 25 | 1.9% | 1.4% | ||
| Q3 25 | 1.3% | 0.7% | ||
| Q2 25 | 1.2% | 2.8% | ||
| Q1 25 | 1.0% | 2.2% | ||
| Q4 24 | 1.9% | 0.8% | ||
| Q3 24 | 1.5% | 0.9% | ||
| Q2 24 | 3.0% | 1.7% | ||
| Q1 24 | 3.3% | 2.5% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | -330.22× | ||
| Q1 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
